Senate Bill Offers Short Reprieve for Full Spectrum CBD Products

Full spectrum CBD products may remain available beyond the November deadline after Senate lawmakers added a temporary hemp provision to a federal spending bill introduced in Washington this week.

The continuing resolution, introduced by leaders of the Senate Appropriations Committee, would fund federal agencies through December 11. Its current language would also delay federal restrictions affecting many hemp-derived products that are scheduled to begin on November 12, 2026.

The delay would keep current rules in place for naturally derived hemp products. Synthetic cannabinoids that the plant does not produce on its own would still be subject to the November deadline.

cbdMD said its primary portfolio, including full spectrum CBD and other naturally derived hemp formulations, appears to fall within the category the Senate proposal is intended to protect. The company welcomed the language but emphasized that the measure has not yet become law.

The House of Representatives previously approved a version of the continuing resolution that did not contain the hemp provisions. For the extension to take effect, lawmakers in both chambers must agree on the final wording. The legislation would then require the president’s signature.

“This is a bridge, not the finish line. It is an encouraging step for our industry and the consumers we serve,” said cbdMD CEO T. Ronan Kennedy.

Kennedy noted that including hemp protections in the main text of a must-pass spending measure is particularly significant. According to cbdMD, the proposed delay could maintain consumer access while giving lawmakers more time to establish clear and lasting federal standards.

cbdMD called for clear rules requiring independent lab testing, accurate labels, age checks, proper manufacturing standards, and tighter oversight of sales. The company said it would continue working with lawmakers and industry groups as the spending bill moves through Congress.

We recall that Congress created the November 12 deadline when it approved tighter limits for hemp products last year. Unless lawmakers intervene, many full spectrum CBD items now sold legally could disappear from the market once those rules begin.

The Senate proposal would not permanently resolve the issue. Instead, it would move the immediate deadline to December 11 and create a limited period for additional negotiations.

During that time, Congress could consider a broader regulatory framework through a Farm Bill, a year-end appropriations package, or another legislative measure.

The latest development follows months of outreach from hemp businesses, farmers, consumers, and industry organizations seeking separate federal rules for naturally derived hemp products and certain synthetic compounds. cbdMD described the proposal as an important temporary step but stressed that further congressional action would still be necessary.